Research Topics
| D SchragSummaryAffiliation: Memorial Sloan-Kettering Cancer Center Country: USA Publications
| Collaborators
|
Detail Information
Publications
Age and adjuvant chemotherapy use after surgery for stage III colon cancerD Schrag
Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
J Natl Cancer Inst 93:850-7. 2001..However, the extent to which adjuvant therapy is used outside the clinical trial setting, particularly among the elderly, is unknown...- Influence of hospital procedure volume on outcomes following surgery for colon cancerD Schrag
Department of Epidemiology and Biostatistics, Health Outcomes Research Group, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
JAMA 284:3028-35. 2000..Conflicting evidence exists as to whether the association between hospital experience and favorable health outcomes also applies to more frequently performed operations, such as those for colon cancer... 
Meeting the 12 lymph node (LN) benchmark in colon cancerA Rajput
Department of Surgical Oncology, Roswell Park Cancer Institute, Buffalo, New York, USA
J Surg Oncol 102:3-9. 2010..Examining >or=12 LN in colon cancer has been suggested as a quality metric. The purpose of this study was to determine whether the 12 LN benchmark is achieved at NCCN centers compared to a US population-based sample...- Who gets adjuvant treatment for stage II and III rectal cancer? Insight from surveillance, epidemiology, and end results--MedicareD Schrag
Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
J Clin Oncol 19:3712-8. 2001..To examine the relationship between patient characteristics and the use of adjuvant pelvic radiation with and without chemotherapy among patients aged 65 years and older with stage II and III rectal cancer... - Young age influences treatment but not outcome of colon cancerH M Quah
Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Ann Surg Oncol 14:2759-65. 2007..The aim of this study was to determine the association between age, clinicopathologic features, adjuvant therapy, and outcomes following colon cancer resection... - The influence of hospital volume on survival after resection for lung cancerP B Bach
Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
N Engl J Med 345:181-8. 2001.... - Use of high technology imaging for surveillance of early stage breast cancerK S Panageas
Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, 307 East 63rd Street, 3rd Floor, New York, NY 10021, USA
Breast Cancer Res Treat 131:663-70. 2012..Strategies to foster judicious utilization of HTRI should be a priority... - Identification of poor prognostic features among patients requiring mechanical ventilation after hematopoietic stem cell transplantationP B Bach
Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Blood 98:3234-40. 2001..The presence of this feature may justify the recommendation to withdraw life-sustaining measures... - Dynamic contrast enhanced-MRI for the detection of pathological complete response to neoadjuvant chemotherapy for locally advanced rectal cancerM J Gollub
Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA
Eur Radiol 22:821-31. 2012..To determine the ability of dynamic contrast enhanced (DCE-MRI) to predict pathological complete response (pCR) after preoperative chemotherapy for rectal cancer...